Study | Year | Country | Number of patients tested | Incidence of Positive Biomarkers (%) | |||
---|---|---|---|---|---|---|---|
MGMT promoter methylation | 1p19q co-deletion | IDH1 mutation | ATRX loss | ||||
Lassman et al. [28] | 2011 | USA | 631 | 48 | |||
Boots-Sprenger et al. [24] | 2013 | Netherlands | 51 (MGMT) | 45 | |||
53 (1p19q) | 51 | ||||||
115 (IDH1) | 75 | ||||||
Wiestler et al. [29] | 2013 | Germany | 133 | 33 | |||
Ogura et al. [20] | 2015 | Japan | 101 | 36 | 35 | ||
Cai et al. [30] | 2016 | China | 104 | 54 | 40 | ||
Ebrahimi et al. [31] | 2016 | Germany | 245 (IDH1/2) | 60a | |||
239 (ATRX) | 34 | ||||||
Polivka et al. [32] | 2016 | Czech Republic | 23 | 52 | |||
Rajmohan et al. [21] | 2016 | India | 91 | 81 | 53 | 84 | 30 |
Kramář et al. [33] | 2016 | Czech Republic | 17 | 71a |